ACUTE LYMPHOCYTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Post-Market watch: tracking a leukemia Drug's Real-World safety
Disease control CompletedThis study monitored the safety and effectiveness of the approved drug BESPONSA in real-world patients in Japan. It included 421 adults and children with a specific type of acute lymphocytic leukemia that had returned or was not responding to other treatments. The main goal was t…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New engineered cell therapy tested in kids with Tough-to-Treat cancers
Disease control CompletedThis study tested a new type of personalized cell therapy for children and young adults whose leukemia or lymphoma had come back or did not respond to standard treatments. Researchers collected a patient's own immune cells, genetically modified them in a lab to recognize a protei…
Matched conditions: ACUTE LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC